Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile.

Calzetta, Luigino; Ludovica Ritondo, Beatrice; de Marco, Patrizia; Cazzola, Mario; Rogliani, Paola

Calzetta, Luigino; Ludovica Ritondo, Beatrice; de Marco, Patrizia; Cazzola, Mario; Rogliani, Paola.

Afiliación

Calzetta L; Department of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy.
Ludovica Ritondo B; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
de Marco P; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
Cazzola M; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
Rogliani P; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.

Expert Rev Respir Med ; 15(4): 579-581, 2021 04.

Article en En | MEDLINE | ID: mdl-33332207

Asunto(s)

Asma; Enfermedad Pulmonar Obstructiva Crónica; Agonistas de Receptores Adrenérgicos beta 2/efectos adversos; Asma/tratamiento farmacológico; Broncodilatadores/efectos adversos; Humanos; Enfermedad Pulmonar Obstructiva Crónica/diagnóstico; Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Peloideterapia Asunto principal: Asma / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Diagnostic_studies Idioma: En Revista: Expert Rev Respir Med Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google